Pharmaceutical manufacturers of Aceclofenac

Aarti Drugs Ltd (ADL) is a part of the Aarti Group of Industries, which has a total worth of USD 500 million. It was established in 1984 and has since developed a strong presence in the fields of Anti-diarrhea and Anti-inflammatory therapeutic groups. The company's manufacturing facilities are located in Tarapur and Sarigam, where it produces a variety of medicines including Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives, and anti-depressant drugs. Over the years, ADL has successfully carved a niche for itself and is now planning to increase its production capacity.

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally. We offer APIs from a wide range of therapeutic classes like NSAIDS, Antifungals, Antidepressants, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories.

We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

Lunan Pharma is a prominent pharmaceutical firm dedicated to enhancing human well-being through the production and promotion of top-quality pharmaceutical products. The company achieved total sales revenues of 1.8 billion dollars in 2020 and is ranked among the top 22 in China.

Hanmi has experienced notable expansion since its establishment in 1973 and has emerged as the most prominent company among pharmaceutical firms in South Korea. We take pride in being recognized as a global frontrunner in the production of high-quality API for cephalosporins, cardiovascular, anti-diabetic, gastrointestinal, and CNS medications. The facilities have undergone inspection and received approval from UK MHRA, German BSG, Australian TGA, and US FDA. Hanmi has successfully developed and introduced new combination drugs and a series of IMDs using its patented process

Bayir is a professionally managed corporation involved in the manufacturing and promotion of specific active Pharmaceuticals, Nutraceutical, and Botanical extracts such as Coleus Forskolin, Glucosamine, Garcinia Extract, Chondroitin sulphate, Herbal Extract, and Curcumin. The manufacturing units of the corporation are furnished with modern facilities operated by highly qualified experts and are WHO cGMP certified.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

Our aim is to become a prominent company in the API and key intermediates industry. Established in 1994, our company is a certified GMP enterprise, specializing in the manufacturing of APIs (Active Pharmaceutical Ingredients), key intermediates of APIs, and fine chemicals. We pride ourselves on delivering high-quality products (APIs and key intermediates) that are meticulously prepared under stringent quality control and exceptional process management. Furthermore, we are a dynamic venture company striving to emerge as a global leader in the generic API industry. Through continuous research and development, we are enhancing our research capabilities and proprietary technology.

Established in the year 2000 as Dongwoo Shintech Co., Ltd., INIST ST has emerged as a pioneer in the advancement of pharmaceutical raw materials and the technology for synthesizing raw materials. Guided by the principles of transformation, innovation, and a passion for life, INIST ST has been engaged in the exploration and production of high-caliber generic raw materials and enhanced drugs through salt modification, commencing with the development of treatments for cerebrovascular diseases and distributing them both nationally and globally. Backed by unwavering trust and expertise, it is utilized as a contrast agent for heart disease and serves as the basis for numerous original active ingredients.

DONGBANG FTL originated under the name Dongbang Synthetic Chemical with the aim of becoming the most well-known and reliable company in the active ingredients sector through honest competition

Korea Biochem Pharm. Inc. is a pharmaceutical company founded in 2010. We distribute approximately 30 different APIs and finished products domestically and also export to Europe. Korea Biochem aims to achieve the status of a globally recognized healthcare company, striving for the betterment of global health culture and the establishment of a welfare society through the highest level of R&D investment and innovative technical skills while upholding the value of life.

KyungDong Pharm is making progress on a global scale. Established in 1975, KyungDong Pharm has been dedicated to developing ethical medicines and creating its own technologies for medicine development, previously reliant on imports. With the belief of leading human health and happiness through sincere and diligent efforts in medicine creation and development, the company has been actively involved in research and development. Currently, it contributes to the health of the Korean population by producing approximately 90 types of ethical medicines, pharmaceutical ingredient medicine, and non-prescription medicine.

Hwail Pharm is a South Korean pharmaceutical company established in 1980. They operate in two main areas: Pharmaceutical Raw Materials: Hwail Pharm manufactures and distributes various ingredients used in the production of medications, including antitussives, expectorants, and anti-inflammatories. Finished Formulations: They also produce and sell finished pharmaceutical products, such as injection solutions like ceftazidime and cefoperazone. The company has its headquarters in Hwaseong, South Korea, and is a significant player in the South Korean pharmaceutical market. They prioritize quality and adhere to international standards in their manufacturing and distribution processes. Additionally, they offer food ingredients beyond pharmaceuticals.

Established in April 1992, SAMO' was founded with the primary goal of advancing the pharmaceutical sector across all nations during the era of independence. Consequently, the company has created 32 employment opportunities and has engaged local industry professionals. Presently, the organization collaborates with medical experts, professors, as well as members of the International Academy of Ecology and Life Safety, possessing dual PhDs and highly skilled personnel. The future of the pharmaceutical field greatly relies on the types and quantities of medications, along with their appropriateness for the population's needs.

Synergy Pharma is one of the API manufacturers in China with most strict quality control. The main API products have DMF-CTD, and the relevant ICH guidelines such as Q7 have been well implemented. It pursues zero defects to pass the official quality system inspection. The main products have passed the on-site GMP inspection by NMPA, USFDA, Japan PMDA, South Korea MFDS and other health authorities. It receives more than 50 customer quality audits every year. The products are exported to more than 50 countries and regions around the world, with the export rate of more than 60%. The export sales turnover to Europe, the United States, Japan and South Korea account for more than 60% of the total sales of the company.

Rivopharm operates as a Swiss business situated close to Lugano in the Ticino region. The primary focus of the company lies in the development and production of pharmaceutical products within the generic sector. With a robust regulatory division, a highly motivated and effective Research and Development team, and a contemporary facility, we are positioned to deliver a client-centric approach to Research and Development, registration, and manufacturing, all while upholding Switzerland's standing for efficiency, top-notch quality, and dependability.

LABOCHEM SA was founded in 1990 as a representative and distribution firm specializing in APIs and excipients for the pharmaceutical, beauty, and chemical sectors, with its main office located in Athens, Greece. Our business operations have expanded globally, covering EU and CIS nations. Labochem creates generic products/dossiers for export and licensing. We also serve as agents for processing and packaging machinery in the pharmaceutical, chemical, beauty, personal care, and food industries.